Table 1.
Parameters | All Samples (n = 89) |
---|---|
Gender (N, %) | |
Male | 51 (57.3%) |
Female | 38 (42.7%) |
Age (median, range in years) | 61 (17–86) |
Age (N, %) | |
≤60 years | 42 (47.2%) |
>60 years | 47 (52.8%) |
Tumor size (N, %) | |
<5 cm | 36 (40.4%) |
≥5 cm | 39 (43.9%) |
Not available | 14 (15.7%) |
Tumor localization | |
Cervical–thoracic–lumbar region | 43 (48.3%) |
Sacrococcygeal region | 46 (51.7%) |
Surgical margin | |
Adequate | 45 (50.6%) |
Inadequate | 25 (28.1%) |
Not available | 19 (21.3%) |
Ki-67 index (median, range) | 3 (1–12) |
Ki-67 index (N, %) | |
≤3% | 43 (48.3%) |
>3% | 37 (41.6%) |
Not evaluable | 9 (10.1%) |
SMARCB1/INI1 immunohistochemical expression (N, %) | |
Positive | 52 (58.4%) |
Positive/negative | 37 (41.6%) |
Previous surgery | |
No | 53 (59.6%) |
Yes | 21 (23.6%) |
Not available | 15 (16.9%) |
Previous treatment | |
No | 59 (66.3%) |
Yes | 14 (15.7%) |
Not available | 16 (18%) |
Type of surgery | |
En bloc resection | 54 (60.7%) |
Other surgery | 16 (18%) |
No surgery | 19 (21.3%) |
Charlson Comorbidity Index (CCI) | |
Mean (SD) | 4.1 (0.260) |